FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893092392> ?p ?o ?g. }

• W2893092392 endingPage "154.e2" @default.
• W2893092392 startingPage "142" @default.
• W2893092392 abstract "Background Fecal incontinence is the uncontrollable loss of stool and has a prevalence of around 7-15%. This condition has serious implications for patients’ quality of life. Current treatment options show unsatisfactory results. A novel treatment option is therefore needed. Objective This systematic review aims to perform a quality assessment and to give a critical overview of the current research available on regenerative medicine as a treatment for fecal incontinence. Study Design A systematic search strategy was applied in PubMed, Cochrane Library, EMBASE, MEDLINE, Web of Science, and Cinahl from inception until March of 2018. Studies were found relevant when the animals or patients in the studied group had objectively determined or induced fecal incontinence, and the intervention must have used any kind of cells, stem cells, or biocompatible material, with or without the use of trophic factors. Studies were screened on title and consecutively on abstract for relevance by 2 independent investigators. The risk of bias of preclinical studies was assessed using the SYstematic Review Centre for Laboratory animal Experimentation risk of bias tool for animal studies, and for clinical studies the Cochrane risk of bias tool for randomized trials was used. Results In all, 34 preclinical studies and 5 clinical studies were included. Animal species, type of anal sphincter injury, intervention, and outcome parameters were heterogenous. Therefore, a meta-analysis could not be performed. The overall risk of bias of the included studies was high. Conclusion The efficacy of regenerative medicine to treat fecal incontinence could not be determined due to the high risk of bias and heterogenicity of the available preclinical and clinical studies. The findings of this systematic review may result in improved study design of future studies, which could help the translation of regenerative medicine to the clinic as an alternative to current treatments for fecal incontinence. Fecal incontinence is the uncontrollable loss of stool and has a prevalence of around 7-15%. This condition has serious implications for patients’ quality of life. Current treatment options show unsatisfactory results. A novel treatment option is therefore needed. This systematic review aims to perform a quality assessment and to give a critical overview of the current research available on regenerative medicine as a treatment for fecal incontinence. A systematic search strategy was applied in PubMed, Cochrane Library, EMBASE, MEDLINE, Web of Science, and Cinahl from inception until March of 2018. Studies were found relevant when the animals or patients in the studied group had objectively determined or induced fecal incontinence, and the intervention must have used any kind of cells, stem cells, or biocompatible material, with or without the use of trophic factors. Studies were screened on title and consecutively on abstract for relevance by 2 independent investigators. The risk of bias of preclinical studies was assessed using the SYstematic Review Centre for Laboratory animal Experimentation risk of bias tool for animal studies, and for clinical studies the Cochrane risk of bias tool for randomized trials was used. In all, 34 preclinical studies and 5 clinical studies were included. Animal species, type of anal sphincter injury, intervention, and outcome parameters were heterogenous. Therefore, a meta-analysis could not be performed. The overall risk of bias of the included studies was high. The efficacy of regenerative medicine to treat fecal incontinence could not be determined due to the high risk of bias and heterogenicity of the available preclinical and clinical studies. The findings of this systematic review may result in improved study design of future studies, which could help the translation of regenerative medicine to the clinic as an alternative to current treatments for fecal incontinence." @default.
• W2893092392 created "2018-10-05" @default.
• W2893092392 creator A5007467013 @default.
• W2893092392 creator A5076653292 @default.
• W2893092392 creator A5086738831 @default.
• W2893092392 date "2019-02-01" @default.
• W2893092392 modified "2023-10-14" @default.
• W2893092392 title "Regenerative medicine as a therapeutic option for fecal incontinence: a systematic review of preclinical and clinical studies" @default.
• W2893092392 cites W1968622650 @default.
• W2893092392 cites W1974257488 @default.
• W2893092392 cites W1978747595 @default.
• W2893092392 cites W1984382670 @default.
• W2893092392 cites W1988821576 @default.
• W2893092392 cites W1996791303 @default.
• W2893092392 cites W2005099534 @default.
• W2893092392 cites W2006721040 @default.
• W2893092392 cites W2009566779 @default.
• W2893092392 cites W2016123783 @default.
• W2893092392 cites W2018981307 @default.
• W2893092392 cites W2022716403 @default.
• W2893092392 cites W2031331609 @default.
• W2893092392 cites W2034807029 @default.
• W2893092392 cites W2035380728 @default.
• W2893092392 cites W2036881012 @default.
• W2893092392 cites W2038936267 @default.
• W2893092392 cites W2042257850 @default.
• W2893092392 cites W2042908790 @default.
• W2893092392 cites W2043122271 @default.
• W2893092392 cites W2046202648 @default.
• W2893092392 cites W2051228098 @default.
• W2893092392 cites W2052629224 @default.
• W2893092392 cites W2053542782 @default.
• W2893092392 cites W2058571677 @default.
• W2893092392 cites W2064498556 @default.
• W2893092392 cites W2069694060 @default.
• W2893092392 cites W2077095885 @default.
• W2893092392 cites W2080236296 @default.
• W2893092392 cites W2086933053 @default.
• W2893092392 cites W2096923422 @default.
• W2893092392 cites W2098923148 @default.
• W2893092392 cites W2109776602 @default.
• W2893092392 cites W2119788531 @default.
• W2893092392 cites W2124415296 @default.
• W2893092392 cites W2147715801 @default.
• W2893092392 cites W2162024779 @default.
• W2893092392 cites W2175638783 @default.
• W2893092392 cites W2313775336 @default.
• W2893092392 cites W2316948358 @default.
• W2893092392 cites W2324418491 @default.
• W2893092392 cites W2338206191 @default.
• W2893092392 cites W2468050463 @default.
• W2893092392 cites W2559830051 @default.
• W2893092392 cites W2590039944 @default.
• W2893092392 cites W2592826666 @default.
• W2893092392 cites W2605432478 @default.
• W2893092392 cites W2611967570 @default.
• W2893092392 cites W2725775368 @default.
• W2893092392 cites W2768071143 @default.
• W2893092392 cites W2784967304 @default.
• W2893092392 cites W2792615283 @default.
• W2893092392 cites W2804599654 @default.
• W2893092392 cites W4294215472 @default.
• W2893092392 doi "https://doi.org/10.1016/j.ajog.2018.09.009" @default.
• W2893092392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30267651" @default.
• W2893092392 hasPublicationYear "2019" @default.
• W2893092392 type Work @default.
• W2893092392 sameAs 2893092392 @default.
• W2893092392 citedByCount "12" @default.
• W2893092392 countsByYear W28930923922020 @default.
• W2893092392 countsByYear W28930923922021 @default.
• W2893092392 countsByYear W28930923922022 @default.
• W2893092392 countsByYear W28930923922023 @default.
• W2893092392 crossrefType "journal-article" @default.
• W2893092392 hasAuthorship W2893092392A5007467013 @default.
• W2893092392 hasAuthorship W2893092392A5076653292 @default.
• W2893092392 hasAuthorship W2893092392A5086738831 @default.
• W2893092392 hasConcept C118552586 @default.
• W2893092392 hasConcept C126322002 @default.
• W2893092392 hasConcept C141071460 @default.
• W2893092392 hasConcept C168563851 @default.
• W2893092392 hasConcept C17744445 @default.
• W2893092392 hasConcept C177713679 @default.
• W2893092392 hasConcept C189708586 @default.
• W2893092392 hasConcept C199539241 @default.
• W2893092392 hasConcept C27415008 @default.
• W2893092392 hasConcept C2776478404 @default.
• W2893092392 hasConcept C2776813522 @default.
• W2893092392 hasConcept C2779473830 @default.
• W2893092392 hasConcept C2781145037 @default.
• W2893092392 hasConcept C535046627 @default.
• W2893092392 hasConcept C71924100 @default.
• W2893092392 hasConcept C95190672 @default.
• W2893092392 hasConceptScore W2893092392C118552586 @default.
• W2893092392 hasConceptScore W2893092392C126322002 @default.
• W2893092392 hasConceptScore W2893092392C141071460 @default.
• W2893092392 hasConceptScore W2893092392C168563851 @default.
• W2893092392 hasConceptScore W2893092392C17744445 @default.
• W2893092392 hasConceptScore W2893092392C177713679 @default.

• next